Morgan Stanley’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-138
| Closed | -$108 | – | 8445 |
|
|
2025
Q4 | $108 | Hold |
138
| – | – | ﹤0.01% | 7700 |
|
|
2025
Q3 | $181 | Sell |
138
-11,774
| -99% | -$14.9K | ﹤0.01% | 7610 |
|
|
2025
Q2 | $45.5K | Buy |
11,912
+11,759
| +7,686% | +$59.6K | ﹤0.01% | 6388 |
|
|
2025
Q1 | $965 | Buy |
153
+8
| +6% | +$69 | ﹤0.01% | 7286 |
|
|
2024
Q4 | $1.6K | Buy |
145
+112
| +339% | +$1.15K | ﹤0.01% | 7228 |
|
|
2024
Q3 | $382 | Buy |
+33
| New | +$931 | ﹤0.01% | 7327 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7839 |
|
|
2024
Q1 | – | Hold |
0
| – | -$46 | – | 7930 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7678 |
|
|
2023
Q1 | – | Hold |
0
| – | -$1 | – | 7798 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7873 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7823 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7922 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8068 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8066 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6684 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6658 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6723 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6713 |
|
|
2018
Q3 | – | Sell |
-43
| Closed | -$107K | – | 6768 |
|
|
2018
Q2 | $107K | Buy |
+43
| New | +$113K | ﹤0.01% | 5727 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6618 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6583 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6628 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6597 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6548 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6543 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6605 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6477 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6510 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6544 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6715 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6616 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6635 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6628 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6438 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6398 |
|
Other funds holding OGEN
TSS
HF
VF
TRCT
AAS
SJIM
Morgan Stanley's OGEN Position: Q1 2026 in Review
Morgan Stanley sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 138 shares — an estimated $108 sold.
Morgan Stanley first reported a position in OGEN in Q2 2018 and held it in 7 quarters. The position peaked at $107K in Q2 2018. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.
- Morgan Stanley reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
- Morgan Stanley sold 138 Oragenics shares in Q1 2026, an estimated $108.
- Morgan Stanley first reported a position in Oragenics in Q2 2018 and held it in 7 quarters.
- Morgan Stanley's Oragenics position peaked at $107K in Q2 2018.
- 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.